BALAXI PHARMACEUTICALS LIMITED (BALAXI) — Cash Flow Quality Index
BALAXI PHARMACEUTICALS LIMITED (BALAXI) has a Cash Flow Quality Index of 29.99x as of September 2025. Operating cash flow of Rs149.66 Million exceeds net income of Rs4.99 Million, indicating high earnings quality where cash backs reported profits. Explore BALAXI PHARMACEUTICALS LIMITED cash flow to debt ratio to assess how comfortably operating cash covers total debt obligations.
Cash Flow Quality Index
Operating Cash Flow
Net Income
Data as of
BALAXI PHARMACEUTICALS LIMITED Cash Flow Quality Index (2013–2026)
Historical Cash Flow Quality Index for BALAXI PHARMACEUTICALS LIMITED across 11 annual periods. Values consistently above 1.0x indicate high-quality earnings. For the full cash flow conversion analysis, see cash flow conversion of BALAXI PHARMACEUTICALS LIMITED.
Annual Cash Flow Quality Index for BALAXI PHARMACEUTICALS LIMITED (2013–2026)
Year-by-year earnings quality comparison for BALAXI PHARMACEUTICALS LIMITED.
| Year | Quality Index | Operating CF (INR) | Net Income | YoY Change |
|---|---|---|---|---|
| 2026 | -5.82x | Rs-82.44 Million | Rs14.17 Million | ▼ -286.1% |
| 2025 | -1.51x | Rs-377.82 Million | Rs250.70 Million | ▼ -162.4% |
| 2024 | 2.41x | Rs48.66 Million | Rs20.15 Million | ▲ +2162.3% |
| 2023 | 0.11x | Rs60.75 Million | Rs569.22 Million | ▼ -83.0% |
| 2022 | 0.63x | Rs341.44 Million | Rs545.22 Million | ▲ +895421.0% |
| 2021 | 0.00x | Rs31.00K | Rs443.29 Million | ▲ +100.0% |
| 2020 | -1.58x | Rs-140.62 Million | Rs88.74 Million | ▼ -156.5% |
| 2019 | -0.62x | Rs-15.07 Million | Rs24.39 Million | ▼ -143.0% |
| 2015 | 1.44x | Rs2.11 Million | Rs1.47 Million | ▲ +165.7% |
| 2014 | -2.19x | Rs-2.39 Million | Rs1.10 Million | ▼ -129.8% |
| 2013 | 7.34x | Rs3.25 Million | Rs442.13K | — |